Patent ID: 7759325

Claim:
A method for treatment of conditions induced by, or appearing in the form of scaly or keratosic abnormal formations of the derma, selected from the group consisting of common psoriasis, guttate psoriasis, nummular psoriasis, plaque psoriasis, erytrhodermic psoriasis, psoriatic arthritis, pustular psoriasis, child psoriasis, parapsoriasis, and chronic and acute dermatitis, comprising administering a medication comprising at least one of a lecithin and a lecithin rich extract, orally, rectally or via direct lymphatic route, said lecithin comprising phospholipids, in an amount by weight of total phospholipids: from 10% to 75% phosphatidylcholine; from 10% to 30% phosphatidylinositol; from 5% to 30% phosphatidylethanolamine; from 5% to 20% phosphatidylserine; from 5% to 30% sphingomyeline, said phospholipids being esterified by Omega 3-type fatty acids.